Movers and Shakers

Alentis Therapeutics hasappointed Mark Pruzanski as new CEO

Ashvattha Therapeutics brings in Robert Dempsey as interim CEO

Basking Biosciences appoints Julia Owens as new CEO

BPGbio has appointed Brian Berman as interimCMO

Cabaletta Bio appointed Steve Gavel as CCO

FairJourney Biologics has appointed Dr. Werner Lanthaler as CEO

Generation Bio saw a CEO transition as Geoff McDonough stepped down, Yalonda Howze takes on the role in the interim

Newleos Therapeutics welcomed Timothy Noyes as CEO and president, replacing David Donabedian

Organon CEO Kevin Ali stepped down after an investigation by the company’s audit committee. Joseph Morrissey has stepped up as interim CEO

OSE Immunotherapeutics, named Marc Le Bozec as interim CEO while OSE searches for a permanent replacement for CEO Nicolas Poirier

Stoke Therapeutics, appoints Ian Smith as its permanent CEO

Teladoc Health CFO Mala Murthy plans to leave the company to pursue an opportunity outside of the healthcare industry

Theolytics has appointed Matilde Saggese as CMO

Valitor appoints Gregory Kunst as CEO